1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Peter Higgins: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Calprotectin-Directed Humira® Maintenance Therapy (CADHUM) Adalimumab, Adalimumab PRN, Placebo - Crohn's Disease | Phase 3 | Withdrawn | Peter Higgins | 2013-10-01 | 2017-05-24 |
Crohn Disease (1) · Inflammatory Bowel Diseases (1)
Adalimumab (1)
United States (1)